109 related articles for article (PubMed ID: 3310850)
1. The c-K-ras gene and human cancer (review).
Kahn S; Yamamoto F; Almoguera C; Winter E; Forrester K; Jordano J; Perucho M
Anticancer Res; 1987; 7(4A):639-52. PubMed ID: 3310850
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of carcinogenesis: the role of oncogenes, transcriptional enhancers and growth factors.
Spandidos DA
Anticancer Res; 1985; 5(5):485-98. PubMed ID: 3904595
[TBL] [Abstract][Full Text] [Related]
3. Activated oncogenes in human tumors.
Suárez HG
Anticancer Res; 1989; 9(5):1331-43. PubMed ID: 2686533
[TBL] [Abstract][Full Text] [Related]
4. Molecular genetics of malignant insulinoma.
Pavelic K; Hrascan R; Kapitanovic S; Vranes Z; Cabrijan T; Spaventi S; Korsic M; Krizanac S; Li YQ; Stambrook P; Gluckman JL; Pavelic ZP
Anticancer Res; 1996; 16(4A):1707-17. PubMed ID: 8712689
[TBL] [Abstract][Full Text] [Related]
5. Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium.
Enomoto T; Fujita M; Inoue M; Rice JM; Nakajima R; Tanizawa O; Nomura T
Cancer Res; 1993 Apr; 53(8):1883-8. PubMed ID: 8385572
[TBL] [Abstract][Full Text] [Related]
6. ras gene activation and infrequent mutation in papillary serous carcinoma of the peritoneum.
Garrett AP; Ng SW; Muto MG; Welch WR; Bell DA; Berkowitz RS; Mok SC
Gynecol Oncol; 2000 Apr; 77(1):105-11. PubMed ID: 10739698
[TBL] [Abstract][Full Text] [Related]
7. The role of oncogenes in human neoplasia.
Aaronson SA; Tronick SR
Important Adv Oncol; 1985; ():3-15. PubMed ID: 3916746
[No Abstract] [Full Text] [Related]
8. Evaluation of potential oncogene alterations in the ENU1564 rat mammary tumor model.
Hal DG; Stoica G
Anticancer Res; 1994; 14(2A):481-7. PubMed ID: 7912494
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms underlying the tumorigenesis of colorectal adenomas: correlation to activated K-ras oncogene.
Wang JY; Wang YH; Jao SW; Lu CY; Kuo CH; Hu HM; Hsieh JS; Chong IW; Cheng TL; Lin SR
Oncol Rep; 2006 Dec; 16(6):1245-52. PubMed ID: 17089045
[TBL] [Abstract][Full Text] [Related]
10. Activation of Raf-1 in human pancreatic adenocarcinoma.
Berger DH; Jardines LA; Chang H; Ruggeri B
J Surg Res; 1997 Apr; 69(1):199-204. PubMed ID: 9202670
[TBL] [Abstract][Full Text] [Related]
11. In vitro modeling of human pancreatic duct epithelial cell transformation defines gene expression changes induced by K-ras oncogenic activation in pancreatic carcinogenesis.
Qian J; Niu J; Li M; Chiao PJ; Tsao MS
Cancer Res; 2005 Jun; 65(12):5045-53. PubMed ID: 15958547
[TBL] [Abstract][Full Text] [Related]
12. Expression of p21 ras oncoproteins in human cancers.
Tanaka T; Slamon DJ; Battifora H; Cline MJ
Cancer Res; 1986 Mar; 46(3):1465-70. PubMed ID: 3510727
[TBL] [Abstract][Full Text] [Related]
13. The product of the cph oncogene is a truncated, nucleotide-binding protein that enhances cellular survival to stress.
Velasco JA; Avila MA; Notario V
Oncogene; 1999 Jan; 18(3):689-701. PubMed ID: 9989819
[TBL] [Abstract][Full Text] [Related]
14. The involvement of oncogenes and suppressor genes in human neoplasia.
Brodeur GM
Adv Pediatr; 1987; 34():1-44. PubMed ID: 3318293
[TBL] [Abstract][Full Text] [Related]
15. Oncogene activation in malignant transformation: a study of H-ras in human breast cancer.
Spandidos DA
Anticancer Res; 1987; 7(5B):991-6. PubMed ID: 3435051
[TBL] [Abstract][Full Text] [Related]
16. Mutational and nonmutational activation of p21ras in rat colonic azoxymethane-induced tumors: effects on mitogen-activated protein kinase, cyclooxygenase-2, and cyclin D1.
Bissonnette M; Khare S; von Lintig FC; Wali RK; Nguyen L; Zhang Y; Hart J; Skarosi S; Varki N; Boss GR; Brasitus TA
Cancer Res; 2000 Aug; 60(16):4602-9. PubMed ID: 10969813
[TBL] [Abstract][Full Text] [Related]
17. Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung.
Vachtenheim J; Horáková I; Novotná H; Opáalka P; Roubková H
Clin Cancer Res; 1995 Mar; 1(3):359-65. PubMed ID: 9815992
[TBL] [Abstract][Full Text] [Related]
18. Oncogenic pathway of sporadic colorectal cancer with novel germline missense mutations in the hMSH2 gene.
Yamada K; Zhong X; Kanazawa S; Koike J; Tsujita K; Hemmi H
Oncol Rep; 2003; 10(4):859-66. PubMed ID: 12792735
[TBL] [Abstract][Full Text] [Related]
19. Oncogenic Ras triggers cell suicide through the activation of a caspase-independent cell death program in human cancer cells.
Chi S; Kitanaka C; Noguchi K; Mochizuki T; Nagashima Y; Shirouzu M; Fujita H; Yoshida M; Chen W; Asai A; Himeno M; Yokoyama S; Kuchino Y
Oncogene; 1999 Apr; 18(13):2281-90. PubMed ID: 10327074
[TBL] [Abstract][Full Text] [Related]
20. Mutations in ras oncogenes: rare events in ultraviolet B radiation-induced mouse skin tumorigenesis.
Khan SG; Mohan RR; Katiyar SK; Wood GS; Bickers DR; Mukhtar H; Agarwal R
Mol Carcinog; 1996 Feb; 15(2):96-103. PubMed ID: 8599584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
